Psyence Biomedical Ltd Stock Ownership - Who owns Psyence Biomedical?

Insider buying vs selling

Have Psyence Biomedical Ltd insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when PBM insiders and whales buy or sell their stock.

PBM Shareholders

What type of owners hold Psyence Biomedical Ltd stock?
Marc Gregory Balkin55.67%7,455,000$3.27MInsider
Newcourt Spac Sponsor LLC6.87%920,000$403.88kInsider
Polar Asset Management Partners Inc3.96%530,000$232.67kInsider
Cantor Fitzgerald L P2.52%337,000$147.94kInstitution
Advisorshares Investments LLC2.03%271,336$119.12kInstitution
Two Sigma Securities LLC0.42%55,776$24.49kInstitution
Virtu Financial LLC0.20%26,419$11.60kInstitution
Cowen And Company LLC0.19%25,000$10.98kInstitution
Hrt Financial LP0.09%12,611$5.54kInstitution
Geode Capital Management LLC0.08%10,488$4.60kInstitution

1 of 2

PBM vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
LIXT2.45%97.55%Net Buying
OGEN0.47%99.53%Net Selling

Psyence Biomedical Stock Ownership FAQ

Who owns Psyence Biomedical?

Psyence Biomedical (NASDAQ: PBM) is owned by 5.53% institutional shareholders, 66.53% Psyence Biomedical insiders, and 27.94% retail investors. Marc Gregory Balkin is the largest individual Psyence Biomedical shareholder, owning 7.46M shares representing 55.67% of the company. Marc Gregory Balkin's Psyence Biomedical shares are currently valued at $2.90M.

If you're new to stock investing, here's how to buy Psyence Biomedical stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.